13.06.2013 • NewsMarathon OilMarathonExxonMobil

Marathon Oil Taps Exxon Mobil Executive as next CEO

Marathon Oil has tapped an Exxon Mobil executive to become its next CEO when Clarence Cazalot retires at the end of the year.

Lee Tillman, Exxon Mobil's vice president of engineering, will take the top post at the energy exploration company in January 2014, Marathon Oil said on Thursday.

Tillman's experience in some of the world's most complex energy fields, including Norway, Scotland and Indonesia, will help Marathon Oil as it works to expand its operations in Canada's oil sands, America's shale fields, and in Iraq and Angola.

Tillman, 51, has worked at Exxon Mobil since 1989 after earning a Ph.D. at Auburn University. A chemical engineer by training, he is a car enthusiast and once said in an interview that as a child, he dreamed of racing Formula 1 cars.

Tillman will join Marathon Oil on Aug. 1 as president and Cazalot, 62, will stay on as executive chairman through the end of the year.

It was not immediately clear if Tillman will remain at Exxon Mobil through August. Exxon Mobil declined to comment.

Dennis Reilley, Marathon Oil's current lead director, will be nominated to become non-executive chairman once Cazalot retires, the company said.

In 2011, Houston-based Marathon Oil spun off its refining unit into Marathon Petroleum.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.